Skip to main content

The team characterise humoral immune responses and develop new therapeutic strategies against complex pathogens

The main research focus of the Immunology (IGG) group is characterization of the immune response to infectious diseases, cancer, and autoimmune diseases. It is currently working on characterizing the humoral response to HIV and SARS-CoV-2, with special emphasis on identifying neutralizing, neutralization-interfering, and pathogenic antibodies. The group is also working on the development of vaccines against challenging pathogens such as HIV, Treponema spp, and SARS-CoV-2, therapeutic antibodies, and new diagnostic tools.

Jorge Carrillo Molina
Principal investigator
Jorge Carrillo Molina
Dr. Carrillo obtained his degree in Biological Sciences from the University of Córdoba (Spain) in 2000. In 2001 he joined Dr. Verdaguer’s group at the Immunobiology Laboratory for Research and…
Go to profile
Not available in
This is not available in . You can go to the translated versions in these languages: